The study of arrhythmias and electrophysiology encompasses cutting-edge research and therapies to address irregularities in cardiac rhythm. From catheter-based ablation techniques to advanced wearable monitoring devices, progress in this field has improved both diagnosis and treatment precision. Conditions like supraventricular tachycardia and long QT syndrome are increasingly understood through sophisticated electrophysiological testing. Additionally, advancements in cryoablation and robotic catheter navigation have minimized procedural risks while enhancing outcomes. Artificial intelligence is also being integrated into electrophysiology to predict arrhythmia episodes and optimize device programming. As the field grows, it holds immense potential to transform arrhythmia care and cardiac health management globally.
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Empathy and precision: Revolutionizing communication between cardiologists and patients
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : Ex-situ organ perfusion and cardiac performance improvement
Y J H J Taverne, Erasmus University Medical Center, Netherlands